BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 11948691)

  • 1. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.
    Soker S; Miao HQ; Nomi M; Takashima S; Klagsbrun M
    J Cell Biochem; 2002; 85(2):357-68. PubMed ID: 11948691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.
    Miao HQ; Soker S; Feiner L; Alonso JL; Raper JA; Klagsbrun M
    J Cell Biol; 1999 Jul; 146(1):233-42. PubMed ID: 10402473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S; Fidder H; Neufeld G; Klagsbrun M
    J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
    Soker S; Takashima S; Miao HQ; Neufeld G; Klagsbrun M
    Cell; 1998 Mar; 92(6):735-45. PubMed ID: 9529250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
    Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
    J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.
    Mamluk R; Gechtman Z; Kutcher ME; Gasiunas N; Gallagher J; Klagsbrun M
    J Biol Chem; 2002 Jul; 277(27):24818-25. PubMed ID: 11986311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
    Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
    Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
    Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
    J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
    Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121).
    Whitaker GB; Limberg BJ; Rosenbaum JS
    J Biol Chem; 2001 Jul; 276(27):25520-31. PubMed ID: 11333271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
    Waltenberger J; Claesson-Welsh L; Siegbahn A; Shibuya M; Heldin CH
    J Biol Chem; 1994 Oct; 269(43):26988-95. PubMed ID: 7929439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
    J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.
    Gagnon ML; Bielenberg DR; Gechtman Z; Miao HQ; Takashima S; Soker S; Klagsbrun M
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2573-8. PubMed ID: 10688880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells.
    Cunningham SA; Tran TM; Arrate MP; Bjercke R; Brock TA
    Am J Physiol; 1999 Jan; 276(1):C176-81. PubMed ID: 9886933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165.
    Soker S; Gollamudi-Payne S; Fidder H; Charmahelli H; Klagsbrun M
    J Biol Chem; 1997 Dec; 272(50):31582-8. PubMed ID: 9395496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
    Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
    Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1.
    Wise LM; Veikkola T; Mercer AA; Savory LJ; Fleming SB; Caesar C; Vitali A; Makinen T; Alitalo K; Stacker SA
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3071-6. PubMed ID: 10077638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
    Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
    J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes.
    Gluzman-Poltorak Z; Cohen T; Shibuya M; Neufeld G
    J Biol Chem; 2001 Jun; 276(22):18688-94. PubMed ID: 11278319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.